Filter
1158
Text search:
drug
regimens
Featured
164
301
Language
Document type
643
217
161
52
31
21
19
7
3
2
1
Countries
71
44
36
30
29
27
25
24
24
23
16
16
15
14
12
12
11
9
9
9
8
8
8
7
7
7
7
7
7
7
6
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
417
191
54
48
28
15
14
Toolboxes
283
121
62
49
40
32
30
25
21
17
16
11
10
9
6
4
4
4
2
2
2
2
2
1
The END TB Strategy
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
treat TB
Description of Research Outputs, 2009 - 2014
11-17 April 2012
8–18 December 2015
First report of a demonstration project
10–21 March 2014
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
Also published in Spanish (2013) with the title: Informe sobre la epilepsia en América Latina y el Caribe - ISBN 978-92-75-31776-1
Setting WHO directions
Epilepsies: diagnosis and management
recommended
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal
...
